Bristol-Myers Squibb logo

Bristol-Myers Squibb

BMY | NYSE
Chart Builder DCF Calculator
$62.48
+$1.09 (+1.78%)
At close: Oct 30, 2026, 4:00 PM ET
$62.55
+$0.07 (+0.11%)
After-hours: Oct 30, 2026, 7:31 PM ET

Market Data

Market Cap
$127.63B
Enterprise Value
$157.92B
Beta
0.23
Average Volume
11.57M
Shares Outstanding (Diluted)
2.05B
Shares Change YoY
0.74%
Institutional Ownership
85.40%
Exchange
NYSE
ISIN
US1101221083

Price Performance

Price Change 1M
0.1%
Price Change 3M
-4.3%
Price Change 6M
7.3%
Price Change YTD
15.8%
Price Change 1Y
35.6%
Price Change 3Y
21.3%
Price Change 5Y
7.0%
1M CAGR (ann.)
0.1%
1Y CAGR (ann.)
53.2%
5Y CAGR (ann.)
5.9%
All-Time CAGR
5.0%

Valuation

PE Ratio
13.85
Forward PE
9.25
PEG Ratio
0.26
Forward PEG
3.10
PS Ratio
2.55
Forward PS
2.60
PB Ratio
5.45
P/FCF Ratio
13.74
P/Adj. FCF Ratio
14.61
P/OCF Ratio
11.99
EV/Sales
3.16
EV/EBIT
12.16
EV/EBITDA
10.42
EV/FCF
17.01
Earnings Yield
7.2%
FCF Yield
7.3%
Adj. FCF Yield
6.8%

Financial Health

Net Debt
$30.3B
Total Debt
$42.88B
Cash & Short-Term Investments
$12.58B
Total Assets
$88.77B
Current Ratio
1.59
Quick Ratio
1.44
Debt / Equity Ratio
1.83
Debt / EBITDA
2.83
Debt / FCF
4.62
OCF / Debt
0.25
Interest Coverage
7.89
Altman Z-Score
2.69
Piotroski F-Score
7

Margins & Profitability

Gross Profit Margin
69.2%
Operating Profit Margin
26.1%
EBITDA Margin
30.3%
Net Profit Margin
18.5%
FCF Margin
18.6%
Adj. FCF Margin
17.5%
SBC / Revenue
1.1%
SBC Impact (per share)
-5.9%

Returns

Return on Assets
10.4%
Return on Equity
43.9%
Return on Invested Capital
15.0%
Return on Capital Employed
18.6%
Return on Tangible Assets
18.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
3.6%
Revenue CAGR 5Y
1.9%
Revenue CAGR 10Y
10.5%
EPS CAGR 3Y
4.6%
EPS CAGR 5Y
8.7%
EPS CAGR 10Y
8.5%
FCF CAGR 3Y
-7.4%
FCF CAGR 5Y
-9.0%
FCF CAGR 10Y
23.8%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
16
EPS Growth Next 3Y
2.1%
Revenue Growth Next 3Y
-9.4%
Earnings Date
Feb 4, 2027
EPS Estimate (next Q)
$1.52
EPS Growth Est (next Q)
20.6%
Revenue Est (next Q)
$12.66B
Revenue Growth Est (next Q)
1.2%

Fair Value Estimates

Graham Number
$34.10
Graham Upside
-45.4%
Lynch Fair Value
$39.33
Lynch Upside
-37.0%
Price Target
$66.08
Price Target Upside
5.8%

Cash Flow

Operating Cash Flow
$10.65B
Free Cash Flow
$9.29B
Adj. Free Cash Flow
$8.73B
FCF Per Share
$4.55
OCF Per Share
$5.21
OCF/S Ratio
21.3%

Income Statement

Revenue
$50.03B
Gross Profit
$34.64B
Operating Income
$13.05B
EBITDA
$15.15B
Net Income
$9.24B
EPS (Diluted)
$4.51
Revenue / Employee
$1.54M
Profit / Employee
$284.4K
Employees
32,500

Dividends

Annual Dividend
$2.52
Dividend Yield
4.03%
Payout Ratio
55.5%
FCF Payout Ratio
55.1%
Adj. FCF Payout Ratio
58.6%
Dividend Growth (YoY)
1.6%
Pay Frequency
Quarterly
Ex-Dividend Date
Oct 2, 2026

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.